1,000-Patient study to decode widespread artery disease
NCT ID NCT07151183
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will collect DNA samples and medical records from 1,000 people with panvascular disease, a condition where arteries in multiple parts of the body are narrowed or blocked. Researchers will analyze this data to better understand what causes the disease and how it progresses. The goal is to improve diagnosis and find more effective treatments for conditions like heart attack, stroke, and peripheral artery disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could lead to better ways to diagnose and treat panvascular diseases, potentially improving patient outcomes.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence clinical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin Medical University
RECRUITINGHarbin, Heilongjiang, 150086, China
Contact Phone: •••-•••-•••• Email: •••••@•••••